MYLAN 5150 MYLAN 5150 Pill - purple capsule/oblong, 15mm
Pill with imprint MYLAN 5150 MYLAN 5150 is Purple, Capsule/Oblong and has been identified as Nizatidine 150 mg. It is supplied by Mylan Pharmaceuticals Inc.
Nizatidine is used in the treatment of GERD; Erosive Esophagitis; Indigestion; Duodenal Ulcer; Duodenal Ulcer Prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 5150 MYLAN 5150
Nizatidine
- Imprint
- MYLAN 5150 MYLAN 5150
- Strength
- 150 mg
- Color
- Purple
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-5150 (Discontinued)
- Inactive Ingredients
-
ammonia,
lactose anhydrous,
silicon dioxide,
D&C Red No. 28,
FD&C Blue No. 1,
FD&C Red No. 40,
gelatin,
isopropyl alcohol,
magnesium stearate,
butyl alcohol,
corn starch,
propylene glycol,
shellac,
dimethicone,
sodium lauryl sulfate,
titanium dioxide,
FD&C Red No. 3
Note: Inactive ingredients may vary.
More about nizatidine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
- En español
Patient resources
- Nizatidine drug information
- Nizatidine (Advanced Reading)
- Nizatidine Capsules and Tablets
- Nizatidine Oral Solution
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
